ResearchSurvival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot study
ResearchStent reconstruction for symptomatic inferior cavoatrial anastomotic stenosis following cardiac transplantation
ResearchA phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
ResearchA Technology-Based Educational Intervention and Multiple Domains of Symptom Experience: Asian American Breast Cancer Survivors
ResearchCorrection: Thymic epithelial tumors at the crossroads of immunity, autoimmunity, and immunotherapy
ResearchAssociations of Biological Aging With Perceived Stress in Patients With Head and Neck Cancer Undergoing Intensity Modulated Radiation Therapy: A Longitudinal Study
ResearchColocated Multidisciplinary Clinic Is Associated With Improved Timeliness to Postoperative Adjuvant Therapy in Head and Neck Cancer Patients
ResearchReal-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
ResearchDNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism
ResearchETV2/ER71 regulates hematovascular lineage generation and vascularization through an H3K9 demethylase, KDM4A
ResearchStatin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
ResearchNeoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
ResearchEarly-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer
ResearchRadiotherapy With Cisplatin vs Carboplatin Paclitaxel for Head and Neck Squamous Cell Carcinoma
ResearchProspective Pilot Study of Second Primary Tumor Prevention With Erlotinib and Celecoxib in Early-Stage Squamous Cell Carcinoma of the Head and Neck: Long-Term Follow-Up